This website uses cookies. By browsing this website, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. To learn more about how we use cookies, please read our Privacy Statement.
HCPCS code A9608 assigned, effective January 1, 2024
REIMBURSEMENT AND FORMULARY SUPPORT
Experience an exceptional level of support
Blue Earth Diagnostics is committed to providing the support you and your patients require
With unparalleled experience in the field of prostate cancer molecular imaging, Blue Earth Diagnostics, Inc. offers extensive education, training, and support
POSLUMA has been granted pass-through status in the Medicare Part B hospital outpatient setting, effective October 1, 2023
Access support starts with your Field Reimbursement manager (FRM). This is your resource for access support, providing information and resources to help you navigate benefits and coverage for POSLUMA.
Your FRM will provide support with:
Coverage policies for payers
Clinical guidelines for radiology benefit managers
Education on prior authorizations, billing, and coding
Support for appeals, denials, and peer-to-peer process
Provide in-person and virtual reimbursement training
The information on this website contains factual information and is not intended to be legal or coding advice. Blue Earth Diagnostics does not guarantee coverage or reimbursement for POSLUMA. The existence of billing codes does not guarantee coverage and payment. Payer policies vary and may change without notice. It is the provider’s responsibility to determine and submit accurate information on claims. This includes submitting proper codes, modifiers, charges, and invoices for the services that were rendered. It is the provider’s responsibility to ensure that all information on a claim is accurate. It is the provider’s responsibility to check with the payer to determine whether the information contained on the claim is accurate. It is the responsibility of the provider to document the medical necessity of POSLUMA in the medical record.
